Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience

被引：7
|
作者：
Schwartz, Jason [1 ]
Thiesset, Heather [2 ]
Box, Terry [3 ]
Hutson, William [4 ]
Sorensen, John [2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Div Surg Transplantat, Dept Surg, Dallas, TX 75390 USA
[2] Univ Utah, Dept Gen Surg, Sect Transplantat, Salt Lake City, UT USA
[3] Univ Utah, Dept Med, Salt Lake City, UT USA
[4] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA
来源：
LIVER TRANSPLANTATION | 2012年 / 18卷 / 11期
关键词：
D O I：
10.1002/lt.23513
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1395 / 1396
页数：2
相关论文
共 50 条
  • [41] Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease
    Lai, Yan-Hua
    Duan, Wei-Dong
    Yu, Qiang
    Ye, Sheng
    Xiao, Nian-Jun
    Zhang, Dong-Xin
    Huang, Zhi-Qiang
    Yang, Zhan-Yu
    Dong, Jia-Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (20) : 6296 - 6303
  • [42] Stem cell therapy for hepatocellular carcinoma and end-stage liver disease
    Mona S. Abdellateif
    Abdel-Rahman N. Zekri
    Journal of the Egyptian National Cancer Institute, 35
  • [43] Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors
    Punch, Jeffrey
    Gish, Robert G.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S122 - S123
  • [44] Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy
    Pomfret, Elizabeth
    Gish, Robert G.
    Brandhagen, David
    LIVER TRANSPLANTATION, 2006, 12 (12) : S100 - S101
  • [45] Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia
    Garcia-Tsao, Guadalupe
    Gish, Robert G.
    Punch, Jeffrey
    LIVER TRANSPLANTATION, 2006, 12 (12) : S108 - S109
  • [46] Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception
    DuBrock, Hilary M.
    del Valle, Kathryn T.
    Krowka, Michael J.
    LIVER TRANSPLANTATION, 2022, 28 (07) : 1224 - 1230
  • [47] Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia
    Gores, Gregory J.
    Gish, Robert G.
    Sudan, Debra
    Rosen, Charles B.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S95 - S97
  • [48] Liver Transplantation for End-Stage Alcoholic Liver Disease: A Single-Center Experience
    Akdur, A.
    Aktas, S.
    Kirnap, M.
    Moray, G.
    Haberal, M.
    TRANSPLANTATION, 2012, 94 (10) : 415 - 415
  • [49] Radio-Pathologic Correlation and Assessment of Patients with End-Stage Liver Disease and Hepatocellular Carcinoma Undergoing Liver Transplantation
    Fiel, M. I.
    Ward, S.
    Thung, S.
    Trivedi, A.
    Fenster, A.
    Florman, S.
    Schiano, T. D.
    MODERN PATHOLOGY, 2014, 27 : 420A - 420A
  • [50] Radio-Pathologic Correlation and Assessment of Patients with End-Stage Liver Disease and Hepatocellular Carcinoma Undergoing Liver Transplantation
    Fiel, M. I.
    Ward, S.
    Thung, S.
    Trivedi, A.
    Fenster, A.
    Florman, S.
    Schiano, T. D.
    LABORATORY INVESTIGATION, 2014, 94 : 420A - 420A
12345